You are here: Home » Adult Webmaster News » FSC PASS Issues Advisory on Mycoplasma Genitalium...
Select year   and month 
March 12, 2019

FSC PASS Issues Advisory on Mycoplasma Genitalium STI

LOS ANGELES �Free Speech Coalition Performer Availability Screening Services (FSC PASS) has issued an advisory on Mycoplasma genitalium (M. Gen) a sexually-transmitted infection that is �rarely tested for in the US but may be increasing in prevalence,� according to the advisory.

�Given the available data and screening guidelines from the CDC and other institutions, we do not at this time believe that it is a serious threat to the performer pool, but we want to provide information to performers as to how to best protect themselves,� FSC PASS said in its advisory.

According to the Centers for Disease Control and Prevention (CDC), M. Gen was �first identified in the early 1980s and has become recognized as a cause of male urethritis, responsible for approximately 15%-20% of nongonococcal urethritis (NGU) cases, 20%�25% of nonchlamydial NGU, and approximately 30% of persistent or recurrent urethritis.�

In its advisory, FSC PASS said M. Gen �has symptoms similar to Chlamydia, including inflammation of the pelvis, vaginal bleeding, painful and/or burning urination, and/or discharge from the urethra.�

�People have also reported itching and general discomfort in their genitals, similar to a yeast infection,� FSC PASS added. �However, like most STIs, it might not present any symptoms. Left untreated over time, it could potentially harm reproductive organs.�

FSC PASS also noted that �the biological makeup of M. Gen makes it difficult to diagnose and treat, however, it is curable.�

Treatment of M. Gen �is typically a course of antibiotics, similar to other bacterial STIs,� FSC PASS said in its advisory.

�Due to possible antibiotic resistance, retesting will be required to confirm that the infection has been cured,� FSC PASS added. �Performers who have been diagnosed should abstain from sexual contact until you have received a confirmation of a negative test result � which can be anywhere from a week to a month after completion of the treatment regimen.�

FSC PASS said the organization is �working with medical professionals and PASS-affiliated testing centers to monitor current research and make sure diagnostic tests are available.�

�FSC is assessing risk and will discuss whether M. Gen will be added to the mandatory panel at the next PASS advisory meeting, anticipated for early April,� FSC PASS added in its advisory. �If you think you have been exposed to M. Gen or have been experiencing any of the above symptoms and have been unable to get a successful diagnosis, we recommend talking to your doctor about M. Gen.�

In its statement, FSC PASS also offered the following links for more information on M. Gen:




home | register | log in | add URL | add premium URL | forums | news | advertising | contact | sitemap
copyright © 1998 - 2009 Adult Webmasters Association. All rights reserved.